These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 21479924)

  • 1. Examining the influence of beta blockers and ACE inhibitors on the risk for breast cancer recurrence: results from the LACE cohort.
    Ganz PA; Habel LA; Weltzien EK; Caan BJ; Cole SW
    Breast Cancer Res Treat; 2011 Sep; 129(2):549-56. PubMed ID: 21479924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of β-blockers, angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and risk of breast cancer recurrence: a Danish nationwide prospective cohort study.
    Sørensen GV; Ganz PA; Cole SW; Pedersen LA; Sørensen HT; Cronin-Fenton DP; Garne JP; Christiansen PM; Lash TL; Ahern TP
    J Clin Oncol; 2013 Jun; 31(18):2265-72. PubMed ID: 23650417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of beta-blockers, angiotensin-converting enzyme inhibitors and angiotensin receptor blockers and breast cancer survival: Systematic review and meta-analysis.
    Raimondi S; Botteri E; Munzone E; Cipolla C; Rotmensz N; DeCensi A; Gandini S
    Int J Cancer; 2016 Jul; 139(1):212-9. PubMed ID: 26916107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison Between Beta-Blockers with Angiotensin-Converting Enzyme Inhibitors and Beta-Blockers with Angiotensin II Type I Receptor Blockers in ST-Segment Elevation Myocardial Infarction After Successful Percutaneous Coronary Intervention with Drug-Eluting Stents.
    Kim YH; Her AY; Jeong MH; Kim BK; Lee SY; Hong SJ; Shin DH; Kim JS; Ko YG; Choi D; Hong MK; Jang Y
    Cardiovasc Drugs Ther; 2019 Feb; 33(1):55-67. PubMed ID: 30632033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of Breast Cancer With Long-Term Use of Calcium Channel Blockers or Angiotensin-Converting Enzyme Inhibitors Among Older Women.
    Raebel MA; Zeng C; Cheetham TC; Smith DH; Feigelson HS; Carroll NM; Goddard K; Tavel HM; Boudreau DM; Shetterly S; Xu S
    Am J Epidemiol; 2017 Feb; 185(4):264-273. PubMed ID: 28186527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic effect of β-blockers in triple-negative breast cancer postmenopausal women.
    Botteri E; Munzone E; Rotmensz N; Cipolla C; De Giorgi V; Santillo B; Zanelotti A; Adamoli L; Colleoni M; Viale G; Goldhirsch A; Gandini S
    Breast Cancer Res Treat; 2013 Aug; 140(3):567-75. PubMed ID: 23912960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular Outcomes in Relation to Antihypertensive Medication Use in Women with and Without Cancer: Results from the Women's Health Initiative.
    Reding KW; Aragaki AK; Cheng RK; Barac A; Wassertheil-Smoller S; Chubak J; Limacher MC; Hundley WG; D'Agostino R; Vitolins MZ; Brasky TM; Habel LA; Chow EJ; Jackson RD; Chen C; Morgenroth A; Barrington WE; Banegas M; Barnhart M; Chlebowski RT
    Oncologist; 2020 Aug; 25(8):712-721. PubMed ID: 32250503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of Antihypertensive Medications and Risk of Adverse Breast Cancer Outcomes in a SEER-Medicare Population.
    Chen L; Chubak J; Boudreau DM; Barlow WE; Weiss NS; Li CI
    Cancer Epidemiol Biomarkers Prev; 2017 Nov; 26(11):1603-1610. PubMed ID: 28807926
    [No Abstract]   [Full Text] [Related]  

  • 9. Associations between diabetes medication use and risk of second breast cancer events and mortality.
    Calip GS; Yu O; Hoskins KF; Boudreau DM
    Cancer Causes Control; 2015 Aug; 26(8):1065-77. PubMed ID: 25956271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined angiotensin-converting enzyme inhibition and receptor blockade associate with increased risk of cardiovascular death in hemodialysis patients.
    Chan KE; Ikizler TA; Gamboa JL; Yu C; Hakim RM; Brown NJ
    Kidney Int; 2011 Nov; 80(9):978-985. PubMed ID: 21775975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta-Blockers and ACE Inhibitors Are Associated with Improved Survival Secondary to Ventricular Tachyarrhythmia.
    Schupp T; Behnes M; Weiß C; Nienaber C; Lang S; Reiser L; Bollow A; Taton G; Reichelt T; Ellguth D; Engelke N; Ansari U; El-Battrawy I; Bertsch T; Akin M; Mashayekhi K; Borggrefe M; Akin I
    Cardiovasc Drugs Ther; 2018 Aug; 32(4):353-363. PubMed ID: 30074111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative safety of cardiovascular medication use and breast cancer outcomes among women with early stage breast cancer.
    Boudreau DM; Yu O; Chubak J; Wirtz HS; Bowles EJ; Fujii M; Buist DS
    Breast Cancer Res Treat; 2014 Apr; 144(2):405-16. PubMed ID: 24557337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monotherapy With Major Antihypertensive Drug Classes and Risk of Hospital Admissions for Mood Disorders.
    Boal AH; Smith DJ; McCallum L; Muir S; Touyz RM; Dominiczak AF; Padmanabhan S
    Hypertension; 2016 Nov; 68(5):1132-1138. PubMed ID: 27733585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of renin-angiotensin-system inhibition on survival and recurrence of N3+ breast cancer patients.
    Babacan T; Balakan O; Kuzan TY; Sarici F; Koca E; Kertmen N; Petekkaya I; Altundag K
    J BUON; 2015; 20(1):50-6. PubMed ID: 25778296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alcohol consumption and breast cancer recurrence and survival among women with early-stage breast cancer: the life after cancer epidemiology study.
    Kwan ML; Kushi LH; Weltzien E; Tam EK; Castillo A; Sweeney C; Caan BJ
    J Clin Oncol; 2010 Oct; 28(29):4410-6. PubMed ID: 20805458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physical activity and risk of recurrence and mortality in breast cancer survivors: findings from the LACE study.
    Sternfeld B; Weltzien E; Quesenberry CP; Castillo AL; Kwan M; Slattery ML; Caan BJ
    Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):87-95. PubMed ID: 19124485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A cohort study of antihypertensive medication use and breast cancer among Danish women.
    Fryzek JP; Poulsen AH; Lipworth L; Pedersen L; Nørgaard M; McLaughlin JK; Friis S
    Breast Cancer Res Treat; 2006 Jun; 97(3):231-6. PubMed ID: 16791484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Administration of angiotensin-converting enzyme inhibitors and β-blockers during adjuvant trastuzumab chemotherapy for nonmetastatic breast cancer: marker of risk or cardioprotection in the real world?
    Oliva S; Cioffi G; Frattini S; Simoncini EL; Faggiano P; Boccardi L; Pulignano G; Fioretti AM; Giotta F; Lestuzzi C; Maurea N; Sabatini S; Tarantini L;
    Oncologist; 2012; 17(7):917-24. PubMed ID: 22673631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of antihypertensive drugs on breast cancer risk in female hypertensive patients: Evidence from observational studies.
    Zhao Y; Wang Q; Zhao X; Meng H; Yu J
    Clin Exp Hypertens; 2018; 40(1):22-27. PubMed ID: 29115847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Outcomes at 2 Years Between Beta-Blockade with ACE Inhibitors or ARBs in Patients with AMI Who Underwent Successful PCI with DES: A Retrospective Analysis of 23,978 Patients in the Korea AMI Registry.
    Kim YH; Her AY; Jeong MH; Kim BK; Hong SJ; Shin DH; Kim JS; Ko YG; Choi D; Hong MK; Jang Y
    Am J Cardiovasc Drugs; 2019 Aug; 19(4):403-414. PubMed ID: 30788675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.